Partners Kathleen Sanzo, Jacqueline Berman, and David Salmons wrote a Law360 Expert Analysis article. They cover how although the Fifth Circuit recently stayed a Texas federal court's ruling that invalidated the US Food and Drug Administration's (FDA) approval of a commonly used abortion medication, several points made by the courts are worth considering for their potential effect on FDA authority and the challenges they may create for the life sciences industry.